Ë¿¹ÏÊÓƵ

Transition report pursuant to Rule 13a-10 or 15d-10

12. Stockholders' Equity (Deficiency) (Details 3)

v2.4.0.8
12. Stockholders' Equity (Deficiency) (Details 3) (USD $)
4 Months Ended
Apr. 30, 2013
Stockholders Equity Deficiency Details 3 [Abstract]  
Number of Options Granted 658,914
Number of Options Exercised   
Number of Options Forfeited (92,500)
Number of Options Expired   
Number of Options Outstanding, Ending 6,777,967
Number of Options Exercisable 2,056,998
Weighted Average Exercise Price Issued $ 0.35
Weighted Average Exercise Price Exercised   
Weighted Average Exercise Price Forfeited $ 0.35
Weighted Average Exercise Price Expired   
Weighted Average Exercise Price Outstanding, Ending $ 0.35
Weighted Average Exercise Price Exercisable $ 0.35
Weighted Average Remaining Contractual Life (in years) Outstanding 4 years 4 months 24 days
Weighted Average Remaining Contractual Life (in years) Exercisable 4 years 4 months 24 days
Aggregate Intrinsic Value Granted   
Aggregate Intrinsic Value Exercised   
Aggregate Intrinsic Value Forfeited/canceled   
Aggregate Intrinsic Value Outstanding, Ending   
Aggregate Intrinsic Value Exercisable